SC
Scilex Holding Company
SCLX · NASDAQ
$4.93 -1.79% (-$0.09)
1M -20.31%
Market Cap $41.9M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$6.8
37.9% upside
Current Price
$4.93
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SCLX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
96 /100
Cheap P/S 1.32x
PEG N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 7.35%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 903.52%
Gross margin 50.47%
FCF margin 56.69%
Quality
59 /100
Average Asset turnover 0.12x
ROIC 162.61%
ROA 176.82%
Debt
0 /100
High Int. coverage -20.98x
Current ratio 0.07x
Debt/Assets N/A
Stability
6 /100
Unstable EPS volatility 365.69%
Beta 1.72x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SCLX
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Henry H. Ji
Employees
34
Headquarters
Palo Alto
Upcoming events
02 DEC
Earnings
Upcoming earnings report